profile

T2B Monthly

Featured Post

🇬🇧 London Biopharma Comms Events in November

Hi! We're headed back to London next month for the Jefferies Healthcare Conference and London Life Sciences Week! With an increasingly international audience gathering for the conference, we're looking forward to bringing together more of our global T2B community through two events focused on giving back and connecting with fellow biopharma communicators. Even if you're not making the trip, we'd love your help spreading the word! Please share these invitations with UK-based colleagues,...

Hi! Many of the decisions we’re asked to make have no clear or obvious correct answer. Taking a public position on an issue may reassure employees, but create political or commercial exposure. Staying silent may protect the company legally but undermine trust with patients or other stakeholders. And sometimes, the pressure to respond quickly doesn't leave much room to think through the longer-term implications. At this Friday's Comm Convo, we'll explore how communicators can help leadership...

Hi! China's role in global biopharma has changed dramatically over the past few years, evolving from a lower-cost manufacturing and research hub into a major source of innovation, drug development, and licensing activity. At the same time, geopolitical tensions and shifting U.S. policies have raised questions about cross-border partnerships, investment, intellectual property, and supply chains. At our upcoming Media Minds Roundtable press panel, we'll hear from Drew Armstrong (Endpoints) and...

Hi! Patient advocacy is often most visible through awareness campaigns, community events, fundraising walks, and patient stories. But that’s of course only part of the picture, and for communicators, PA&E may be part of our own remit or something we engage with across the organization. At our next Patient Advocacy & Engagement Roundtable event, we’re turning the conversation over to the Roundtable members themselves for a candid, myth-busting discussion about what PA&E does, where it...

Hi! A quick reminder that our next Digital & Social Media Roundtable event is tomorrow, and we’re getting very practical about what the next generation of the press release should look like. We'll get into the choices communicators are making around the release itself and the broader package of content that surrounds it, including: What we would keep, change, or eliminate if we were reinventing the press release today The structure, context, and supporting information that help LLMs...

Hi! Employee giving and volunteer programs can deliver value well beyond employee engagement. Done thoughtfully, they can strengthen company culture and employer brand, deepen community relationships, and create authentic stories that support corporate reputation. At our recent SF Bay Area T2Bmeet, hosted by Exelixis, we explored how the company is realizing these benefits through Exelixis CARES, from making participation easier and empowering employee ambassadors to creating content that...

Hi! Applications are now open for five member spots of our Digital & Social Media Roundtable. We invite biopharma communicators from in-house, agency, and consulting roles to apply to help advance our collective capabilities in this space, by creating resources and programming to support the T2B community more broadly. What the Digital & Social Media roundtable focuses on Christopher Rizzo, Head of Digital and Social Strategy at Syneos Health Communications, will take over as chair for Year 2...

Hi! In recent years, communicators have invested more heavily in owned channels, social, executive voices, and earned media, while the press release started to feel more like an obligatory staple than a strategic asset. Now, as LLMs and answer-based search increasingly rely on authoritative, on-domain information, the release is having a renaissance. It still needs to work for journalists and to satisfy disclosure requirements, but it also has to be discoverable, structured, credible, and...

Hi! That's a wrap on Day 1 of our Virtual Biopharma Comms Forum, and now looking forward to Day 2 tomorrow! We covered a lot of ground today focused on the theme Owning the Outcome, but across three very different conversations, we looked for the common threads: >> Start with the outcome before choosing the activity. We kept hearing versions of the same question: What are we actually trying to change? That could mean the business problem a comms strategy needs to help solve, the stakeholder...

Hi! A quick reminder that our 2nd Annual Virtual Biopharma Comms Forum starts tomorrow, October 6th. Over the next two half-days, we’ll gather virtually to explore what the expansion of the comms remit means for the profession, and how we as communicators can Own the Outcome (this year's forum theme). Our agenda approaches this from multiple angles: From how the C-suite experiences comms counsel, to the changing boundaries of corporate affairs and measuring what matters to the business. Sign...